Volume 9, Number 12—December 2003
Research
Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo
Daniel G. Bausch*1
, Matthias Borchert†2, Thomas Grein‡, Cathy Roth‡, Robert Swanepoel§, Modeste L. Libande¶, Antoine Talarmin#3, Eric Bertherat**4, Jean-Jacques Muyembe-Tamfum¶, Ben Tugume††, Robert Colebunders†, Kader M. Kond采5, Patricia Pirard§§, Loku L. Olinda¶, Guénaël R. Rodier‡, Patricia Campbell¶¶, Oyewale Tomori‡‡, Thomas G. Ksiazek*, and Pierre E. Rollin*
, Matthias Borchert†2, Thomas Grein‡, Cathy Roth‡, Robert Swanepoel§, Modeste L. Libande¶, Antoine Talarmin#3, Eric Bertherat**4, Jean-Jacques Muyembe-Tamfum¶, Ben Tugume††, Robert Colebunders†, Kader M. Kond采5, Patricia Pirard§§, Loku L. Olinda¶, Guénaël R. Rodier‡, Patricia Campbell¶¶, Oyewale Tomori‡‡, Thomas G. Ksiazek*, and Pierre E. Rollin*Table 1
Demographic characteristics and Marburg immunoglobulin G antibody results of the study population in Durba, Democratic Republic of the Congo, 1999a
| Characteristic | All participants n = 912 (%) | IgG antibody positive n = 15 (%) | IgG antibody negative n = 897 (%) | OR (95% CI) | p value |
|---|---|---|---|---|---|
| Male |
594 (65) |
13 (87) |
581 (65) |
3.5 (0.8 to 15.4) |
0.10 |
| Mean age, y (range) |
31 (14–79) |
27 (21–42) |
31 (14–79) |
- |
0.04 |
| Profession |
- |
||||
| Miner |
347 (38) |
13 (87) |
334 (37) |
11.0 (2.5 to 48.9) |
< 0.001 |
| Merchant |
141 (15) |
0 (-) |
141 (16) |
- |
0.15 |
| Other/unknown | 424 (46) | 2 (13) | 422 (47) | - | - |
aOdds ratios (OR) and p values are for the comparison between antibody-positive and -negative participants. CI, confidence interval; Ig, immunoglobulin.
